Showing results (241-250 of 338) with videos related to
Sort By:
Pageof 34
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancerJohn K Lee, Nathanael J Bangayan, Timothy Chai, et al.Human Pathology|October 7, 2008
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickersRochelle A Simon, P Anthony di Sant'Agnese, Li-Shan Huang, et al.Biorxiv : the Preprint Server for Biology|July 17, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypesAnmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.Biorxiv : the Preprint Server for Biology|June 12, 2026
Visibly Transparent, Near-Infrared Absorbing Nanofluids Enable High-Efficiency and Safe Laser LithotripsyQingsong Fan, Junqin Chen, Arpit Mishra, et al.Oncotarget|July 9, 2014
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistanceMan Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, et al.Journal of Vascular and Interventional Radiology : JVIR|May 28, 2017
CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor YieldMichael G Holmes, Erik Foss, Gabby Joseph, et al.British Journal of Cancer|October 5, 2023
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotypeMichelle Shen, Shiqin Liu, Angus Toland, et al.Molecular Carcinogenesis|April 30, 2014
Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinomaLisha Wang, Sean R Williamson, Shaobo Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2019
Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46Yen-Nien Liu, Shaoxi Niu, Wei-Yu Chen, et al.Oncotarget|September 8, 2018
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistanceMan Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, et al.Pageof 34